Refitting Frequent Replacement Lens Wearers Into Clariti 1 Day And 1-Day Acuvue Moist Daily Disposable Spherical Lenses

August 4, 2020 updated by: CooperVision, Inc.

Refitting Frequent Replacement Lens Wearers Into Clariti 1 Day And 1-Day Acuvue Moist Daily Disposable Spherical Lenses (BEAGLE 2)

The objective of the study is to evaluate and compare the performance of somofilcon A to etafilcon A when worn on a daily disposable wear modality over a period of approximately one week.

Study Overview

Status

Completed

Conditions

Detailed Description

The study is a prospective, double masked (investigator and participant), bilateral, randomized, cross-over dispensing study, which evaluates somofilcon A (test lens) and etafilcon A (control lens).

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Waterloo, Ontario, Canada, N2L 3G1
        • University of Waterloo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subjects will only be eligible for the study if:

    1. Is at least 17 years of age and has full legal capacity to volunteer;
    2. Has read and signed an information consent letter;
    3. Is willing and able to follow instructions and maintain the appointment schedule;
    4. Habitually wears silicone hydrogel frequent replacement soft contact lenses, for minimum of 6-months;
    5. Is correctable to a visual acuity of 20/40 or better (in each eye) with the study lenses;
    6. Can be fit with study contact lenses with a power between - 0.50 and -10.00 DS;
    7. Demonstrates an acceptable fit with the study lenses;
    8. Habitually wears contact lenses for at least 8 hours per day, and willing to wear contact lenses for at least 12 hours a day in the study.

      Exclusion Criteria:

  • Subjects will not be eligible to take part in the study if:

    1. Is participating in any concurrent clinical or research study;
    2. Has any known active* ocular disease and/or infection;
    3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
    4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
    5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
    6. Is pregnant, lactating or planning a pregnancy at the time of enrolment (verbal confirmation at the screening visit);
    7. Is aphakic;
    8. Has undergone refractive error surgery;
    9. Is an employee of the Centre for Ocular Research & Education;
    10. Has participated in the BEAGLE (EX-MKTG-104) study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: somofilcon A
Subjects will be randomized to wear somofilcon A daily disposable lenses for one week and then switch to etafilcon A daily disposable lenses for one week.
Contact Lens
Other Names:
  • Clariti 1-Day
Active Comparator: etafilcon A
Subjects will be randomized to wear etafilcon A daily disposable lenses for one week and then switch to somofilcon A daily disposable lenses for one week.
Contact Lens
Other Names:
  • 1-Day Acuvue Moist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lens Handling for Lens Insertion
Time Frame: Day 1
Lens handling for lens insertion (subjective rating; 0 - 10 integer scale, 0 - very difficult, 10 - very easy)
Day 1
Lens Handling for Lens Insertion
Time Frame: Day 3
Lens handling for lens insertion (subjective rating; 0 - 10 integer scale, 0 - very difficult, 10 - very easy)
Day 3
Lens Handling for Lens Insertion
Time Frame: Day 5
Lens handling for lens insertion (subjective rating; 0 - 10 integer scale, 0 - very difficult, 10 - very easy)
Day 5
Lens Handling for Lens Insertion
Time Frame: 1 Week
Lens handling for lens insertion (subjective rating; 0 - 10 integer scale, 0 - very difficult, 10 - very easy)
1 Week
Lens Handling for Lens Removal
Time Frame: Day 1
Lens handling for lens removal (subjective rating; 0 - 10 integer scale, 0 - very difficult, 10 - very easy)
Day 1
Lens Handling for Lens Removal
Time Frame: Day 3
Lens handling for lens removal (subjective rating; 0 - 10 integer scale, 0 - very difficult, 10 - very easy)
Day 3
Lens Handling for Lens Removal
Time Frame: Day 5
Lens handling for lens removal (subjective rating; 0 - 10 integer scale, 0 - very difficult, 10 - very easy)
Day 5
Lens Handling for Lens Removal
Time Frame: 1 week
Lens handling for lens removal (subjective rating; 0 - 10 integer scale, 0 - very difficult, 10 - very easy)
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lens Centration
Time Frame: Baseline (after 10 minutes of lens fitting)
Lens Centration was measured on a scale of 0-3 (0 - optimal, 1 - slight decentration, 2- moderate decentration but not encroaching limbus, 3 - excessive & occasionally encroaching limbus)
Baseline (after 10 minutes of lens fitting)
Lens Centration
Time Frame: 1 week
Lens Centration was measured on a scale of 0 - 3 (0-optimal, 1-slight decentration, 2-moderate decentration but not encroaching limbus, 3-excessive & occasionally encroaching limbus)
1 week
Post-blink Movement
Time Frame: Baseline (after 10 minutes of lens fitting)
Post-blink movement in primary gaze, in 0.1mm steps
Baseline (after 10 minutes of lens fitting)
Post-blink Movement
Time Frame: 1 -week
Post-blink movement in primary gaze, in 0.1mm steps
1 -week
Push-up Tightness
Time Frame: Baseline (after 10 minutes of lens fitting)
Push-up tightness in primary gaze was measured using a scale 0-100 (5% steps) (0% = falls from cornea without lid support, 50% = optimum, 100% = no movement)
Baseline (after 10 minutes of lens fitting)
Push-up Tightness
Time Frame: 1 week
Push-up tightness in primary gaze was measured using a scale 0-100 (5% steps) (0% = falls from cornea without lid support, 50% = optimum, 100% = no movement)
1 week

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective Ratings of Comfort After Lens Insertion
Time Frame: Baseline
Subjective Ratings of Comfort After Lens Insertion was measured on a scale of 0-10 (0-Painful, 10- Can't feel the lenses).
Baseline
Subjective Ratings of Comfort After Lens Insertion
Time Frame: 1 Day
Subjective Ratings of Comfort After Lens Insertion was measured on a scale of 0-10 (0-Painful, 10- Can't feel the lenses).
1 Day
Subjective Ratings of Comfort After Lens Insertion
Time Frame: Day 3
Subjective Ratings of Comfort After Lens Insertion was measured on a scale of 0-10 (0-Painful, 10- Can't feel the lenses).
Day 3
Subjective Ratings of Comfort After Lens Insertion
Time Frame: Day 5
Subjective Ratings of Comfort After Lens Insertion was measured on a scale of 0-10 (0-Painful, 10- Can't feel the lenses).
Day 5
Subjective Ratings of Comfort After Lens Insertion
Time Frame: 1-Week
Subjective Ratings of Comfort After Lens Insertion was measured on a scale of 0-10 (0-Painful, 10- Can't feel the lenses).
1-Week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lyndon Jones, University of Waterloo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 24, 2019

Primary Completion (Actual)

February 12, 2020

Study Completion (Actual)

March 11, 2020

Study Registration Dates

First Submitted

December 10, 2019

First Submitted That Met QC Criteria

December 10, 2019

First Posted (Actual)

December 12, 2019

Study Record Updates

Last Update Posted (Actual)

August 18, 2020

Last Update Submitted That Met QC Criteria

August 4, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EX-MKTG-112

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on somofilcon A

Subscribe